Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Fifth Annual National General Medical Oncology Summit

2026년 6월 15일 · 노트보기

Podcasts

이 에피소드에 관해

Featuring perspectives from Dr Manali Kamdar, Dr Krish Patel and Dr Gilles Salles, including the following topics:

Introduction (0:00)
Antibody-Drug Conjugates and Other Novel Strategies for the Management of Diffuse Large B-Cell Lymphoma (DLBCL) — Prof Salles (7:05)
Current and Future Role of Monoclonal and Bispecific Antibodies in the Management of DLBCL — Dr Patel (26:21)
Chimeric Antigen Receptor (CAR) T-Cell Therapy for DLBCL — Dr Kamdar (43:12)
CAR T-Cell Therapy for Follicular Lymphoma (FL) — Prof Salles (1:08:33)
Other Approved and Emerging Novel Therapies for FL — Dr Patel (1:24:44)
Integrating Bispecific Antibodies into the Management of FL — Dr Kamdar (1:41:34)

CME information and select publications

과학

의학

영어

미국

API를 사용하여JSON에서 이 에피소드를 가져옵니다.

이 에피소드 내

dr gilles salle

# krish patel

dr manali kamdar

이 태그 수정하기

노트보기 🔗

00:00:00Introduction

00:07:05Antibody-Drug Conjugates and Other Novel Strategies for the Management of Diffuse Large B-Cell Lymphoma (DLBCL) — Prof Salles

00:26:21Current and Future Role of Monoclonal and Bispecific Antibodies in the Management of DLBCL — Dr Patel

00:43:12Chimeric Antigen Receptor (CAR) T-Cell Therapy for DLBCL — Dr Kamdar

01:08:33CAR T-Cell Therapy for Follicular Lymphoma (FL) — Prof Salles

01:24:44Other Approved and Emerging Novel Therapies for FL — Dr Patel

01:41:34Integrating Bispecific Antibodies into the Management of FL — Dr Kamdar

전사 🔗

Are you the producer of this podcast? Add a podcast transcript

Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

과거 에피소드 검색

Hematologic Oncology Update의 과거 에피소드를 검색하세요.

이 검색 창을 웹 사이트에 삽입

이 팟캐스트의 다른 에피소드

Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 3

2026년 9월 6일

Featuring perspectives from Prof John Seymour, including the following topics: Safety of fixed-duration acalabrutinib/venetoclax for chronic lymphocytic leukemia (CLL) (0:00) Venetoclax re-treatment and ongoing trials with acalabrutinib/venetoclax for CLL (6:21) First-line treatment with sonrotocl…